Recent Posts
- A032201: Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-risk renal cell carcinoma – STRIKE (NCT06661720)
- GOG3115/M25-231
- LUCERNA 8951-CL-0305
- GY025: Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- Enhancing Inclusivity in Oncology Clinical Trials: Key Strategies from the ACORI Community Oncology-Inclusive Clinical Trial Design Summit
Recent Comments
No comments to show.